- Home
- CMPS
as 11-15-2024 4:00pm EST
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
| Founded: | 2020 | Country: | United Kingdom |
| Employees: | N/A | City: | CHESIRE |
| Market Cap: | 362.6M | IPO Year: | 2020 |
| Target Price: | $30.67 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.05 - $12.75 | Next Earning Date: | 10-31-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of COMPASS Pathways Plc American Depository Shares (CMPS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ATAI Life Sciences N.V. | CMPS | 10% Owner | Sep 26 '24 | Sell | $6.05 | 2,660,000 | $16,093,000.00 | 6,905,774 |
Latest COMPASS Pathways Plc American Depository Shares News
CMPS Breaking Stock News: Dive into CMPS Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Compass Pathways to participate in Stifel 2024 Healthcare Conference
TipRanks
15 days ago
Compass Pathways cuts 30% of workforce on Phase 3 trial delays
GuruFocus.com
16 days ago
Compass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
Motley Fool
17 days ago
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
BioPharma Dive
18 days ago
Compass delays anticipated psilocybin readout, cuts staff
Business Wire
18 days ago
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
Business Wire
25 days ago
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
Business Wire
2 months ago
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
Compare CMPS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CMPS COMPASS Pathways Plc American Depository Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.